Defense Department,
The DoD (referred to herein as "the Department", "Department of War" or "DoW") is announcing a new demonstration project under the TRICARE program, titled the "TRICARE Demonstration Project for Pre-Hospital Blood Transfusion Ambulance Add-On Reimbursement," also called "The TRICARE PHBT Demonstration" or "PHBTD". This five-year demonstration will test the effectiveness of providing separate, unbundled add-on reimbursement to the TRICARE ambulance fee schedule for the cost of medically necessary blood products and professional services administered by authorized ambulance providers in a pre-hospital (ambulance, air or ground) setting. The goal is to evaluate whether this payment modification improves health outcomes for trauma patients, impacts total cost of care, enhances beneficiary access to care and network adequacy, and is a feasible and advisable permanent change to the TRICARE reimbursement methodology for ambulance services.
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Defense Office of the Secretary AGENCY: Defense Health Agency, Department of Defense (DoD). ACTION: Notice of demonstration project. SUMMARY: The DoD (referred to herein as “the Department”, “Department of War” or “DoW”) is announcing a new demonstration project under the TRICARE program, titled the “TRICARE Demonstration Project for Pre-Hospital Blood Transfusion Ambulance Add-On Reimbursement,” also called “The TRICARE PHBT Demonstration” or “PHBTD”. This five-year demonstration will test the effectiveness of providing separate, unbundled add-on reimbursement to the TRICARE ambulance fee schedule for the cost of medically necessary blood products and professional services administered by authorized ambulance providers in a pre-hospital (ambulance, air or ground) setting. The goal is to evaluate whether this payment modification improves health outcomes for trauma patients, impacts total cost of care, enhances beneficiary access to care and network adequacy, and is a feasible and advisable permanent change to the TRICARE reimbursement methodology for ambulance services. DATES: This demonstration project will be effective January 1, 2027. Demonstration Duration: The demonstration will run for a period of five years, concluding on December 31, 2031. Defense Health Agency (DHA) may extend the demonstration to allow for further data collection and analysis; extensions will be published in the i…
Citation: 91 FR 40985
